| Financial Year |
March 31 2023 |
| Monetary Funds |
76,477,800.42 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
30,930,245.22 |
| Accounts Receivable |
247,693,876.92 |
| Advances to Suppliers |
44,666,390.60 |
| Other Receivables |
4,500,153.73 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
616,662,488.87 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
86,855,023.07 |
| Total Current Assets |
1,109,551,971.40 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
746,129.53 |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
1,558,230,072.21 |
| Under-construction Projects |
135,508,923.80 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
55,130,619.14 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
1,189,815.86 |
| Deferred Income Tax Assets |
61,102,327.71 |
| Other Non-Current Assets |
69,332,535.56 |
| Sub-Total of Non-Current Assets |
1,886,676,349.82 |
| Total Assets |
2,996,228,321.22 |
| Short-Term Loans |
62,307,847.18 |
| Trading Financial liabilities |
-- |
| Notes Payable |
157,829,223.89 |
| Accounts Payable |
185,967,675.03 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
27,755,110.64 |
| Taxes Payable |
25,229,598.00 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
515,337,054.65 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
166,974,598.00 |
| Other Current Liabilities |
32,983,437.14 |
| Sub-Total of Current Liabilities |
1,183,971,122.38 |
| Long-term Loans |
1,051,631,968.74 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
448,756,610.63 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
15,973,491.41 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
1,564,588,574.53 |
| Total Liabilities |
2,748,559,696.91 |
| Paid-In Capital(Or Share Stock) |
136,125,000.00 |
| Capital Surplus |
175,681,975.43 |
| Surplus Reserve |
19,047,234.49 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-83,086,083.65 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
247,668,624.31 |
| Owner's Equity（Stockholder's Equity） |
247,668,624.31 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,996,228,321.22 |
